INCREASED GENERATION OF CYSTEINYL LEUKOTRIENES IN KAWASAKI-DISEASE

被引:13
作者
MAYATEPEK, E [1 ]
LEHMANN, WD [1 ]
机构
[1] GERMAN CANC RES CTR,DEPT CENT SPECT,W-6900 HEIDELBERG,GERMANY
关键词
KAWASAKI DISEASE; CYSTEINYL LEUKOTRIENES; LEUKOTRIENE;
D O I
10.1136/adc.72.6.526
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Endogenous cysteinyl leukotriene synthesis was assessed in 10 patients with Kawasaki disease and 10 healthy controls by measuring excretion of leukotriene E(4) (LTE(4)) in urine. LTE(4) was increased more than fivefold in patients with Kawasaki disease compared with controls (median (range) 55.3 (31.8-120.6) v 10.2 (7.1-14.9) nmol/mol creatinine); this suggests that cysteinyl leukotrienes are involved in the pathophysiology of Kawasaki disease. Leukotriene synthetase inhibition or receptor antagonism may therefore offer a new potential therapeutic approach in children with this disease.
引用
收藏
页码:526 / 527
页数:2
相关论文
共 7 条
  • [1] INCREASED URINARY LEUKOTRIENE EXCRETION IN PATIENTS WITH CARDIAC ISCHEMIA - INVIVO EVIDENCE FOR 5-LIPOXYGENASE ACTIVATION
    CARRY, M
    KORLEY, V
    WILLERSON, JT
    WEIGELT, L
    FORDHUTCHINSON, AW
    TAGARI, P
    [J]. CIRCULATION, 1992, 85 (01) : 230 - 236
  • [2] HAMADA T, 1989, APPL MICROBIOL BIOT, V31, P346
  • [3] INCREASED SYNTHESIS OF THROMBOXANE-A2 BY PLATELETS FROM PATIENTS WITH KAWASAKI DISEASE
    HIDAKA, T
    NAKANO, M
    UETA, T
    KOMATSU, Y
    YAMAMOTO, M
    [J]. JOURNAL OF PEDIATRICS, 1983, 102 (01) : 94 - 96
  • [4] Kato H, 1988, Pediatr Rev, V9, P209, DOI 10.1542/pir.9-7-209
  • [5] KAWASAKI T, 1974, PEDIATRICS, V54, P271
  • [6] MAYATEPEK E, 1995, PEDIATR RES, V37, P1
  • [7] IMPAIRED DEGRADATION OF LEUKOTRIENES IN PATIENTS WITH PEROXISOME DEFICIENCY DISORDERS
    MAYATEPEK, E
    LEHMANN, WD
    FAULER, J
    TSIKAS, D
    FROLICH, JC
    SCHUTGENS, RBH
    WANDERS, RJA
    KEPPLER, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) : 881 - 888